Pneumonia due to Cryptococcus in an immunocompetent host is typically treated with which antifungal regimen and duration?

Pneumonia due to Cryptococcus in an immunocompetent host is typically treated with which antifungal regimen and duration?

• A. Amoxicillin-clavulanate for 7 days
• B. Amphotericin B
• C. Fluconazole or Itraconazole x 3-6 months
• D. Acyclovir

Answer: (C)

In immunocompetent patients with pulmonary cryptococcosis, the infection is typically treated with an oral azole antifungal for several months. Fluconazole or itraconazole given for about 3–6 months provides effective fungal clearance and relapse prevention in this setting. Amphotericin B is reserved for more severe disease or CNS involvement, where induction therapy is needed. Antibacterial regimens like amoxicillin-clavulanate target bacteria, not fungi, and acyclovir is used for herpesviruses, not Cryptococcus. So the best approach for pulmonary cryptococcosis in an otherwise healthy host is fluconazole or itraconazole for roughly 3–6 months, with duration adjusted based on clinical and radiographic response.

In immunocompetent patients with pulmonary cryptococcosis, the infection is typically treated with an oral azole antifungal for several months. Fluconazole or itraconazole given for about 3–6 months provides effective fungal clearance and relapse prevention in this setting. Amphotericin B is reserved for more severe disease or CNS involvement, where induction therapy is needed. Antibacterial regimens like amoxicillin-clavulanate target bacteria, not fungi, and acyclovir is used for herpesviruses, not Cryptococcus. So the best approach for pulmonary cryptococcosis in an otherwise healthy host is fluconazole or itraconazole for roughly 3–6 months, with duration adjusted based on clinical and radiographic response.